CCND1 and embryonal neoplasm: Our results using a cyclin D1-dependent hematologic malignancy, a MYC-dependent embryonal tumor, and a PI3K-dependent solid tumor demonstrate that SRX3177 is efficacious and non-toxic in vitro to normal epithelial cells.